Endoscopic Retrograde Cholangiopancreatography

NCT07490132 — Recruiting, 100 participants, Methodist Health System

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

Endoscopic Retrograde Cholangiopancreatography Patient Registry

Registry	NCT07490132
Status	Recruiting
Study type	Observational
Enrollment	100 (Estimated)
Sponsor	Methodist Health System (Other)
Conditions	Gastro-Intestinal Disorder
Interventions	Patients undergoing ERCPs at Methodist Dallas Medical Center (Other)
Dates	start 2026-02-01 (estimated), primary completion 2027-02-01 (estimated), completion 2028-02-01 (estimated), first posted 2026-03-24, last updated 2026-03-24
Locations	1 site in United States

-Summary

The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.

Expand all sections · Collapse all

+Detailed description

The primary objective of this study is to provide a mechanism to store the following information about patients undergoing ERCPs at Methodist Dallas Medical Center. This registry will be permissive of quality improvement and research studies.

+Arms and interventions

Arm	Type	Interventions	Description
Underwent ERCP		Other: Patients undergoing ERCPs at Methodist Dallas Medical Center	Underwent ERCP between January 1, 2000 through December 31, 2025

Patients undergoing ERCPs at Methodist Dallas Medical Center (Other): The registry will include all patients who meet registry inclusion. Enrollment will terminate once 25 years of data are captured: January 1, 2000 through December 31, 2025.

+Outcome measures

Primary outcomes

Underwent ERCP [25 years]: Patients undergoing ERCPs at Methodist Dallas Medical Center.

+Eligibility

Sex: All, ages: 15 Years to any

Inclusion Criteria:

Patients >15 years Included in MDI's Registry Underwent ERCP between January 1, 2000 through December 31, 2025

Exclusion Criteria:

Patients <15 years Patients in which cannulation was via a surgical anastomosis Patients in which cannulation was not attempted due to gastric outlet obstruction, the main papilla not found, or the minor papilla was not found will be excluded.

+Locations (1)

Facility	City	Country	Status
Methodist Dallas Medical Center- Clinical Research Institute	Dallas, Texas	United States	Recruiting

+Investigators

Prashant Kedia, MD, Principal investigator, Methodist Health System